February 26, 2013 - Blood Cancer Treatment - Making Informed Choices
Your order contains item(s)
View Order
Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.
Date: February 26, 2013
Time: 1:00 p.m. - 2:00 p.m. ET
Location: Telephone/Web
Read: Program Slides | Transcript
Listen: Presentation | Q&A Session
Access: Virtual Lecture
Topics Covered
- Understanding goals of treatment for your diagnosis
- Understanding your treatment options
- Benefits and risks for standard treatments and investigational treatments
- Key facts about clinical trials
Speaker
Stephen D. Nimer, MD
Director
Sylvester Comprehensive Cancer Center
Professor of Medicine, Biochemistry & Molecular Biology
University of Miami Miller School of Medicine
Miami, FL
Questions Asked by the Blood Cancer Community
- I was diagnosed with cytopenia (a reduction in the number of cells circulating in the blood). Do you recommend getting a bone marrow aspiration or biopsy? What about a second opinion?
- With a diagnosis of relapsed chronic lymphocytic leukemia, is a stem cell transplant the next treatment step?
- Why do some patients relapse and become resistant to treatment?
- If lenalidomide (Revlimid®) is not working, can a patient switch to pomalidomide (Pomalyst®)?
- Is being a bone marrow donor dangerous?
- At what point does treatment start for a patient diagnosed with chronic lymphocytic leukemia?
- Is whole genome sequencing done routinely? How can a patient get a personalized approach to treatment?
Sponsors and Supporters
This program is sponsored by The Leukemia & Lymphoma Society and supported by grants from Celgene Corporation and Millennium: The Takeda Oncology Company.
